New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT05199753
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 20 times
Summary
This study tested a new drug called LM-108, alone or with an anti-PD-1 antibody, in 78 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. Early results focus on controlling tumor growth, not curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Hospital
Melbourne, Victoria, VIC 3004, Australia
-
Blacktown Hospital
Sydney, New South Wales, NSW 2148, Australia
-
Cabrini Health Limited
Malvern, Victoria, VIC 3144, Australia
-
ICON Cancer Centre
South Brisbane, Queensland, QLD 4101, Australia
-
One Clinical Research Pty Ltd.
Nedlands, Western Australia, WA 6009, Australia
-
Sunshine Coast University Private Hospital
Birtinya, Queensland, QLD 4575, Australia
Conditions
Explore the condition pages connected to this study.